NTLA compared with CRSP: revenue, margins and what each company keeps, and the suppliers and customers both name

NTLAIntellia Therapeutics, Inc.

Mkt capRevenueRevenue

CRSPCRISPR Therapeutics AG

Mkt capRevenueRevenue

Compare

NTLAIntellia Therapeutics, Inc.

CRSPCRISPR Therapeutics AG

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NTLA 4

REGNRegeneron Pharmaceuticalscustomer

CRBUCaribou Biosciencessupplier

—AvenCell Therapeuticsunlistedcustomer

—SparingVision SASunlistedcustomer

Shared 0

No shared counterparties.

Only CRSP 5

LLYEli Lillycustomer

VRTXVertexcustomer

VERXVertex Pharmaceuticalscustomer

ACETAdicet Biocustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

1 more · CRSP chain ›

NTLAIntellia Therapeutics, Inc.

11.35▲+2.23%· post 11.31

Mkt cap$1.6BRevenue$7MQ3 FY26Revenue$68MFY25

CRSPCRISPR Therapeutics AG

50.08▲+3.13%· post 50.00

ClosedNov 6 '26

Mkt cap$4.9BRevenue$13MQ3 FY26Revenue$4MFY25

Compare

ClosedNov 6 '26

NTLAIntellia Therapeutics, Inc.

CRSPCRISPR Therapeutics AG

11.35▲+2.23%post 11.31

Price

50.08▲+3.13%post 50.00

$1.6B

Mkt cap

$4.9B

Q3 FY26$7M

Revenue

$13MQ3 FY26

FY25$68M

Revenue

$4MFY25

NTLA11.35▲+2.23%vsCRSP50.08▲+3.13%ClosedNov 6 '26